Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$11.11
$11.28
$6.90
$14.85
$43.66B0.621.66 million shs1.26 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$234.67
+0.1%
$234.02
$149.04
$251.71
$564.91B0.277.58 million shs5.46 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.92
+0.1%
$26.86
$22.88
$28.75
$147.72B0.3537.77 million shs22.30 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
0.00%+1.93%-0.80%-11.40%+58.71%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.47%+3.17%-4.42%+53.26%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+2.41%-4.03%-4.13%+11.08%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$11.11
$11.28
$6.90
$14.85
$43.66B0.621.66 million shs1.26 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$234.67
+0.1%
$234.02
$149.04
$251.71
$564.91B0.277.58 million shs5.46 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.92
+0.1%
$26.86
$22.88
$28.75
$147.72B0.3537.77 million shs22.30 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
0.00%+1.93%-0.80%-11.40%+58.71%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.47%+3.17%-4.42%+53.26%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+2.41%-4.03%-4.13%+11.08%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
3.22
BuyN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.74
Moderate Buy$253.047.83% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.6110.39% Upside

Current Analyst Ratings Breakdown

Latest PFE, JNJ, and BAYRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2026
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
UpgradeHoldStrong-Buy
5/14/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$26.00
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeHoldOutperform
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeMarket PerformOutperform$265.00
5/8/2026
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
UpgradeStrong SellHold
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
4/29/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$26.00 ➝ $27.00
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/20/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$25.00
4/16/2026
Pfizer Inc. stock logo
PFE
Pfizer
Initiated CoverageOutperform$33.00
(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$51.55B0.85$2.18 per share5.09$7.50 per share1.48
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$96.36B5.86$14.14 per share16.60$33.73 per share6.96
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.36$4.40 per share5.89$15.86 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
-$4.10B-$0.64N/A8.293.54-4.75%17.74%4.88%8/4/2026 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6527.1318.652.2921.83%32.60%13.29%7/15/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.799.06N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest PFE, JNJ, and BAYRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.64$0.79+$0.15$0.82$15.77 billion$15.73 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
3/4/2026Q4 2025
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.18$0.1794-$0.0006$1.47$13.08 billion$13.24 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.020.18%N/AN/A N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.28%+5.25%61.97%64 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.64%-13.20%131.30%16 Years

Latest PFE, JNJ, and BAYRY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
1.22
1.01
0.63
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
88,0783.93 billionN/ANot Optionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Swedbank AB Raises Holdings in Pfizer Inc. $PFE
St. Louis Trust Co Takes Position in Pfizer Inc. $PFE
2 Reasons to Watch PFE and 1 to Stay Cautious
Pfizer Juggles Trial Win, Setback and New Vaccine Bet

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bayer Aktiengesellschaft stock logo

Bayer Aktiengesellschaft OTCMKTS:BAYRY

$11.11 0.00 (0.00%)
As of 05/22/2026 04:00 PM Eastern

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$234.67 +0.33 (+0.14%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$234.43 -0.25 (-0.10%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$25.92 +0.02 (+0.07%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$25.91 -0.01 (-0.03%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.